Clinical Trial Update: Autologous Stem Cell Transplantation: International Lupus Trial [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial investigating autologous stem cell transplantation for refractory systemic lupus erythematosus was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Autologous stem cell transplantation (autologous stem cell transplantation)

Snippet

Sponsor: European Society for Blood and Marrow Transplantation | Conditions: REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS | Phase 2, Phase 3 | Status: WITHDRAWN